New research suggests that patients recovering from bowel cancer surgery may be at a higher risk of relapse if their blood shows an immune response to a particular protein.
Researchers at the Cardiff Institute of Infection and Immunity have discovered one of the secrets of cytomegalovirus that allows this virus to persist within the salivary glands and subsequently disseminate through saliva
